Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind randomized placebo-controlled trial of Mecasin + riluzole in amyotrophic lateral sclerosis
KCT0001984Phase 2Not yet recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mecasin, riluzole in amyotrophic lateral sclerosis (ALS), sponsored by Ministry of Health & Welfare. Planned start Aug 2016; status: not yet recruiting.
02
Drugs
Mecasinriluzole
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on KCT0001984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001984.